(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 22.87% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.84%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Personalis's revenue in 2025 is $84,614,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2025 to be $7,389,930,460, with the lowest PSNL revenue forecast at $7,308,198,673, and the highest PSNL revenue forecast at $7,480,223,784. On average, 3 Wall Street analysts forecast PSNL's revenue for 2026 to be $9,622,461,586, with the lowest PSNL revenue forecast at $9,108,769,361, and the highest PSNL revenue forecast at $10,027,589,991.
In 2027, PSNL is forecast to generate $14,454,081,195 in revenue, with the lowest revenue forecast at $13,128,455,158 and the highest revenue forecast at $15,779,707,232.